Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RIPK2 | O43353 | 3/20 | 0.36 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | TGFBR1 | P36897 | 2/20 | 0.36 |
| ▸ | KDR | P35968 | 1/20 | 0.36 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.33 |
| ▸ | RIPK3 | Q9Y572 | 1/20 | 0.32 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.32 |
| ▸ | MAP3K8 | P41279 | 2/20 | 0.31 |
| ▸ | SIRT2 | Q8IXJ6 | 1/20 | 0.31 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.31 |
| ▸ | ALK | Q9UM73 | 1/20 | 0.31 |
| ▸ | PTGIR | P43119 | 1/20 | 0.31 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21665688 | 0.88 | MAPT (0.39) | PTGIRPDK2 | |
| SCHEMBL21665622 | 0.86 | PTGIR (0.42) | EGFRPTGIRPDK2 | |
| SCHEMBL23765083 | 0.83 | ALDH1A1 (0.33) | PTGIR | |
| SCHEMBL22245911 | 0.83 | MAPT (0.37) | PTGIR | |
| SCHEMBL21665630 | 0.82 | SIRT2 (0.45) | SIRT2SIRT1ALKPDK2 | |
| SCHEMBL24724160 | 0.81 | PIM3 (0.33) | RIPK2EGFRTGFBR1KDRPIM3 | |
| SCHEMBL24969742 | 0.81 | RIPK2 (0.34) | RIPK2EGFRTGFBR1KDRLIMK1 | |
| SCHEMBL15250350 | 0.81 | SIRT2 (0.46) | SIRT2SIRT1ALKPDK2 | |
| SCHEMBL22680496 | 0.81 | PTGIR (0.40) | PTGIR | |
| SCHEMBL29839680 | 0.80 | AKR1C3 (0.39) | SIRT2SIRT1ALKPDK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200039993-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD (KR) | 2020-02-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200039993-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE1, WEE2 | RIPK2 3659/4885EGFR 2016/4885TGFBR1 3344/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.